MedPath

山东新华鲁抗医药有限公司

Ownership
-
Established
2002-09-19
Employees
-
Market Cap
-
Website
http://www.xhlkyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Macrogol Sodium Potassium Powder

Product Name
聚乙二醇钠钾散
Approval Number
国药准字H20249734
Approval Date
Dec 17, 2024
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20233200
Approval Date
Aug 4, 2023
NMPA

Olmesartan Medoxomil Tablets

Product Name
奥美沙坦酯片
Approval Number
国药准字H20233072
Approval Date
Jun 25, 2023
NMPA

Lansoprazole for Injection

Product Name
注射用兰索拉唑
Approval Number
国药准字H20223831
Approval Date
Nov 8, 2022
NMPA

Methylprednisolone Tablets

Product Name
甲泼尼龙片
Approval Number
国药准字H20213671
Approval Date
Aug 25, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.